Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...
UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...
Zacks Investment Research on MSN
KORU Medical secures EU MDR certification for Freedom60 infusion pump
KORU Medical Systems, Inc. KRMD recently announced that its Freedom60 Infusion Pump — along with an adapter designed for 50 ...
Zacks Investment Research on MSN
SRPT stock up as enrollment begins in DMD gene therapy safety study
Shares of Sarepta Therapeutics SRPT rose about 2% yesterday after it announced that screening and enrollment are underway in ...
Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the ...
The certification expands access to Freedom60 and FreedomEDGE infusion pumps for growing SCIg prefilled syringe use.
Dr. Sanjay P. Ahuja shares insight into Innovative Hematology’s Gene Therapy Hub, the first of its kind in Indiana.
A handful of small, early-stage clinical trials are investigating whether CAR-T therapy can improve symptoms in multiple ...
Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis ...
The Freedom60 Infusion Pump is designed to support dosing with 50 ml prefilled syringes, while the FreedomEDGE® Infusion System provides a compatible option for 20 mL prefilled syringe formats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results